During the EMT at the molecular level, tumor cells switch their epithelial markers, including epithelial cadherin (E-cadherin), zona occludens-1 (ZO-1), and claudin into mesenchymal markers, such as neural cadherin (N-cadherin) fibronectin and vimentin. Here, CDH2 is linked to neoplasm.